Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 8/20 | 0.42 |
| ▸ | MMP2 | P08253 | 8/20 | 0.38 |
| ▸ | MMP3 | P08254 | 6/20 | 0.38 |
| ▸ | ADAM17 | P78536 | 7/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.36 |
| ▸ | MMP14 | P50281 | 1/20 | 0.36 |
| ▸ | MMP13 | P45452 | 4/20 | 0.36 |
| ▸ | TNF | P01375 | 1/20 | 0.36 |
| ▸ | MMP8 | P22894 | 1/20 | 0.36 |
| ▸ | MMP12 | P39900 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8197269 | 1.00 | MMP1 (0.42) | MMP1MMP2MMP3ADAM17MMP9 | |
| SCHEMBL7513209 | 0.85 | MMP1 (0.44) | MMP1MMP2MMP3ADAM17MMP9 | |
| SCHEMBL7410121 | 0.83 | MMP2 (0.47) | MMP1MMP2MMP3 | |
| SCHEMBL8190217 | 0.82 | MMP1 (0.40) | MMP1MMP2MMP3ADAM17MMP9 | |
| SCHEMBL9010568 | 0.81 | MMP1 (0.35) | MMP1MMP2MMP3ADAM17MMP9 | |
| SCHEMBL8189744 | 0.81 | MMP1 (0.40) | MMP1MMP2MMP3ADAM17MMP9 | |
| SCHEMBL8190215 | 0.81 | MMP1 (0.40) | MMP1MMP2MMP3ADAM17MMP9 | |
| SCHEMBL8422654 | 0.80 | MMP1 (0.34) | MMP1MMP2MMP3ADAM17MMP9 | |
| SCHEMBL8198199 | 0.78 | ADAM17 (0.34) | MMP1MMP2MMP3ADAM17MMP9 | |
| SCHEMBL9010562 | 0.78 | ADAM17 (0.34) | MMP1MMP2MMP3ADAM17MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0740655-B1 | METALLOPROTEINASE INHIBITORS | BRITISH BIOTECH PHARM (GB) | 1999-10-20 | — | — | EP | claimed |
| EP-0740655-A1 | METALLOPROTEINASE INHIBITORS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1996-11-06 | — | — | EP | claimed |
| WO-1995019961-A1 | METALLOPROTEINASE INHIBITORS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1995-07-27 | — | — | WO | claimed |
| US-6017889-A | Metalloproteinase inhibitors | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 2000-01-25 | — | — | US | disclosed |
| EP-0740655-B1 | METALLOPROTEINASE INHIBITORS | BRITISH BIOTECH PHARM (GB) | 1999-10-20 | — | — | EP | disclosed |
| EP-0740655-A1 | METALLOPROTEINASE INHIBITORS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1996-11-06 | — | — | EP | disclosed |
| WO-1995019961-A1 | METALLOPROTEINASE INHIBITORS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1995-07-27 | — | — | WO | disclosed |